responds < response < responses

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 186.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000000 (2009)	Susan P. Bruce [États-Unis]	Recent Developments in the Treatment of Rheumatoid Arthritis
000008 (2010)	P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]	Tocilizumab
000010 (2011)	Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]	Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000011 (2012)	Emilio Besada [Norvège] ; Johannes C. Nossent [Norvège]	Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
000013 (2013)	Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]	Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000016 (2009)	Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]	The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000025 (2014)	Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]	Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
000048 (2012)	Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]	Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000059 (2012)	Kevin Kwan [Australie] ; Sneha Bharadwaj [Australie] ; Charles Inderjeeth [Australie]	Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette‐Guérin unresponsive to DMARDs
000065 (2012)	César Faillace [Brésil] ; Jozélio Freire De Carvalho [Brésil]	Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000071 (2010)	A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]	Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000074 (2010)	Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]	Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000075 (2011)	J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]	Tocilizumab: is there life beyond anti‐TNF blockade?
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000094 (2011)	Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]	Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
000099 (2010)	Chi Chiu Mok [Hong Kong] ; Lai Shan Tam [Hong Kong] ; Tak Hin Chan [Hong Kong] ; Gavin K. W. Lee [Hong Kong] ; Edmund K. M. Li [Hong Kong]	Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
000105 (2012)	M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez	Indirect comparison of biological treatments in refractory rheumatoid arthritis
000113 (2005)	Josef S. Smolen [Autriche] ; Kurt Redlich [Autriche] ; Jochen Zwerina [Autriche] ; Daniel Aletaha [Autriche] ; Günter Steiner [Autriche] ; Georg Schett [Autriche]	Pro-inflammatory cytokines in rheumatoid arthritis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "response" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "response" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    response
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021